J
Josemir W. Sander
Researcher at UCL Institute of Neurology
Publications - 705
Citations - 44517
Josemir W. Sander is an academic researcher from UCL Institute of Neurology. The author has contributed to research in topics: Epilepsy & Population. The author has an hindex of 106, co-authored 680 publications receiving 39038 citations. Previous affiliations of Josemir W. Sander include University of Cincinnati & National Institute for Health Research.
Papers
More filters
Journal ArticleDOI
Long-term outcome of phenobarbital treatment for epilepsy in rural China: A prospective cohort study
Patrick Kwan,Wenzhi Wang,Jianzhong Wu,Shichuo Li,Hongchao Yang,Ding Ding,Zhen Hong,Xiuying Dai,Bing Yang,Taiping Wang,Chenglin Yuan,Guangyu Ma,Hanneke M. de Boer,Josemir W. Sander +13 more
TL;DR: Evaluating the long‐term outcome of phenobarbital treatment for convulsive epilepsy in rural China and exploring factors associated with overall seizure outcomes to evaluate the long-term outcome.
Journal ArticleDOI
Decreasing the risk of sudden unexpected death in epilepsy: structured communication of risk factors for premature mortality in people with epilepsy.
Rohit Shankar,William Henley,C. Boland,Richard Laugharne,Brendan McLean,Craig Newman,Jane Hanna,Simone Ashby,Matthew C. Walker,Josemir W. Sander +9 more
TL;DR: The aim of this study was to ascertain if the introduction of the Checklist in epilepsy clinics led to individual risk reduction.
Journal ArticleDOI
The long-term retention of pregabalin in a large cohort of patients with epilepsy at a tertiary referral centre.
Alan W.C. Yuen,Rinki Singh,Gail S. Bell,Anupam Bhattacharjee,Aidan Neligan,Dominic Heaney,John S. Duncan,Josemir W. Sander +7 more
TL;DR: The common adverse experiences (AEs) leading to withdrawal were CNS-related, psychiatric AEs and weight gain, and Published retention rates for levetiracetam appear to be higher, and those for gabapentin lower, than the rates estimated for PGB.
Journal ArticleDOI
Erythrocyte and plasma fatty acid profiles in patients with epilepsy: Does carbamazepine affect omega-3 fatty acid concentrations?
Alan W.C. Yuen,Josemir W. Sander,Dominique Flügel,Philip N. Patsalos,Lucy M. Browning,Gail S. Bell,Matthias M. Koepp +6 more
TL;DR: The effect of CBZ effect in reducing omega-3 FAs might potentially explain some cases of SUDEP among patients prescribed CBZ, as arrhythmias are thought to be an important mechanism in coronary heart disease mortality and sudden unexplained death in epilepsy.
Journal ArticleDOI
Electroencephalographic features of convulsive epilepsy in Africa: A multicentre study of prevalence, pattern and associated factors
Symon M. Kariuki,Symon M. Kariuki,Steven White,Eddie Chengo,Ryan G. Wagner,Ryan G. Wagner,Kenneth Ayuurebobi Ae-Ngibise,Angelina Kakooza-Mwesige,Honorati Masanja,Anthony K. Ngugi,Josemir W. Sander,Brian G. R. Neville,Charles R. Newton,Charles R. Newton +13 more
TL;DR: Electroencephalographic abnormalities are common in Africans with epilepsy and helpful in identifying focal epilepsy in Africa, where timing of focal aetiologies is problematic and there is a lack of neuroimaging services.